Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection

Lancet Diabetes Endocrinol. 2020 Jun;8(6):472-473. doi: 10.1016/S2213-8587(20)30149-2. Epub 2020 Apr 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Insufficiency / drug therapy
  • Adrenal Insufficiency / immunology
  • Adrenal Insufficiency / physiopathology*
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Comorbidity
  • Contraindications, Drug
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / immunology
  • Coronavirus Infections / physiopathology*
  • Critical Illness
  • Cytokine Release Syndrome / physiopathology*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Humans
  • Hydrocortisone / administration & dosage
  • Hydrocortisone / adverse effects*
  • Hypothalamo-Hypophyseal System / drug effects
  • Pandemics
  • Pituitary-Adrenal System / drug effects
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / physiopathology*
  • Practice Guidelines as Topic
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • Hydrocortisone